Intravenous Solutions (Parenteral Nutrition): Market Research Report

June 2013 | 182 pages | ID: I8555A20603EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Millimeter Wave Equipment in US$ Thousand.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2018.

The report profiles 40 companies including many key and niche players such as Aviat Networks, Inc., BridgeWave Communications, Inc., DragonWave, Inc., E-Band Communications Corporation, ELVA-1, INTRACOM TELECOM, NEC Corp., Siklu Communication Ltd., and Trex Enterprises Corporation.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs.

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Intravenous Solutions: A Key Aspect of the Parenteral Nutrition Market
Healthcare Economics amidst the Economic Crisis
The Road Ahead

Table 1. World Intravenous Solutions (Parenteral Nutrition Market): Market Share Breakdown of Different Regional Markets (includes corresponding Graph/Chart)

Table 2. World Intravenous Solutions (Parenteral Nutrition Market): Growth Potential Across Different Regional Markets (includes corresponding Graph/Chart)

Noteworthy Market Trends, Drivers, and Issues
Non-volitional Nutritional Support Therapy - Vital for Combating Malnutrition during Hospitalization

Table 3. Daily Requirements for Adults (Male and Female) by Nutrient Type

Table 4. Energy Requirements by Age and Gender (includes corresponding Graph/Chart)

Table 5. Protein and Vitamin Requirements by Gender

Table 6. Mineral Requirements by Gender and Mineral Type

Rapidly Ageing Demographics to Propel Demand for Intravenous Solutions (Parenteral Nutrition)
Opportunity Indicator

Table 7. Elderly Population (65+ Years) as a Percentage of the Total Population: 2000 & 2025 (includes corresponding Graph/Chart)

Table 8. Global Population Statistics for the 65+ Age Group: 2012

Intravenous Therapy in Outpatient Settings to Boost Market Growth
Growing Demand for Home Intravenous Therapies
Rising Incidence of Chronic Diseases to Propel Growth of IV Solutions Market
Cancer Incidence Statistics

Table 9. New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 10. Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 11. Cancer Incidence in High Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 12. Cancer Incidence in Upper Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 13. Cancer Incidence in Lower Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 14. Cancer Incidence in Low Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Diabetes Mellitus Incidence Statistics
Parental Nutrition Therapy Indicated for Diabetes Patients with Non-functional Gastrointestinal Tract

Table 15. Worldwide Prevalence of Diabetes Mellitus by Region: 2012 & 2030 (includes corresponding Graph/Chart)

Table 16. Prevalence of Diabetes Mellitus in Europe (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Table 17. Prevalence of Diabetes Mellitus in South East Asia (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %) (includes corresponding Graph/Chart)

Table 18. Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Table 19. Prevalence of Diabetes Mellitus in South & Central America (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Table 20. Prevalence of Diabetes Mellitus in Africa (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Table 21. Prevalence of Diabetes Mellitus in Middle East & North Africa (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Global HIV Statistics

Table 22. Global Summary of the AIDS Epidemic in 2011

Table 23. Global HIV Statistics for the Year 2010

Parenteral Nutrition in Select Gastrointestinal Disorders
Intravenous Infusion Technology to Influence the Future Growth Prospects
Pre-mixed IV Solutions: A Step towards Safer Medication Practices
The Need for Low-Cost Solutions
Continuous Supply of Raw Material: Crucial for Production of IV Solutions
Rising Popularity of Intravenous Vitamin C for Cancer Treatment
Increasing Demand for Peripheral Intravenous Nutrition
Iron Replacement Therapies: An Opportunity Area for Intravenous Solutions (Parenteral Nutrition)
Issues
Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
Cost Containment Continues to Pressurize Product Pricing
Infection Control: A Prime Concern in IV Therapy
Complacency of Hospitals & Worker/Patient Safety: A Key Issue
Competition In the Parenteral Nutrition Market

Table 24. Leading Players in the Global Parenteral Nutrition Market (2012): Percentage Share Breakdown of Value Sales for Baxter, Fresenius Kabi, B. Braun Melsungen, Hospira and Others (includes corresponding Graph/Chart)

2. INTRAVENOUS SOLUTIONS

Intravenous Therapy
Defining Intravenous Solutions
Tonicity and Osmolality
Production of IV Solutions
Types of IV Solutions
Colloid Solutions
Crystalloid Solutions
Properties of IV Solution Type Based on Concentration
Isotonic Crystalloids
Hypertonic Crystalloids
Hypotonic Crystalloids
Commonly Used Crystalloid Solutions
Saline Solution
Normal Saline
Half-Normal Saline
Quarter-Normal Saline
Hypertonic Saline
Dextrose
Saline with Additional Ingredients
Intravenous Sugar Solution
Dextrose Solutions or D5W
Other Types
Pre-mixed IV Solutions
Large and Small Volume Intravenous Solutions
Devices Used in IV Solutions Administration
Types of Intravenous Access Devices
Peripheral Cannula
Central IV Lines
Implantable Ports
Tunneled Lines
Peripherally Inserted Central Catheter (PICC)
IV Fluid Packaging
Possible Risks in Intravenous Therapy
Embolism
Electrolyte Imbalance
Extravasation/Infiltration
Phlebitis
Infection

3. PARENTERAL NUTRITION – AN OVERVIEW

An Introduction
Parenteral Nutrition
Sources of Parenteral Solutions
Routes of Administration
Types of Parenteral Nutrition Solutions
Total Parenteral Nutrition (TPN)
Daily Requirements for Total Parenteral Nutrition (TPN) in Adults
Daily Recommended Parenteral Nutritional Intakes for Newborns
Partial Parenteral Nutrition (PPN)
Home Parenteral Nutrition
Parenteral Nutrition Formulations
Standard Solutions
Non-Standard Solutions
Classification of Parenteral Nutrition by Type of Nutrients
Amino Acids
Carbohydrates
Lipids
Minerals & Electrolytes
Micronutrients
Vitamins
Trace Elements
Large and Small Volume Parenteral Solutions
Large Volume Parenteral (LVP) Solutions
Small Volume Parenteral (SVP) Solutions
IV Fat Emulsions – Enabling Maintenance of Bodyweight
Regulatory Prerequisites

4. PRODUCT LAUNCHES

FDA Clears Fresenius Kabi for Emergency Import of Injectionable TPN Drugs
Marck Biosciences Receives MCC Approval for Pharma Products (South Africa)
EC Grants Clearance for Ferumoxytol IV Iron Therapy
Claris Receives USFDA Approval for Marketing Products in the US (US)
Taiho to Roll Out Aloxi 0. 75mg I. V Infusion Bag
Baxter International Launches OLIMEL Emulsion
Baxter International Launches NUMETA in Europe
B. Braun Rolls Out NuTRIflex Omega
Episys Launches New Version of Ultimate Parenteral Nutrition Module

5. RECENT INDUSTRY ACTIVITY

Hospira Recalls IV Electrolyte Solution
Becton, Dickinson and Company Takes over Cato Software Solutions
Otsuka Pharmaceutical Factory Forms a JV with Claris Lifesciences and Mitsui
B. Braun Establishes Pharmaceutical Plant in Fogelsville, US
Baxter International Completes Acquisition of SIGMA International (US)
Aperture Health Takes Over Triad Therapeutics (US)
Children's Hospitals and Clinics of Minnesota Deploys Cerner CareAwareiBusTM of CareFusion
Baxter Initiates Class I Recall of Automix Compounder
Tosho Acquires Minority Interest in Health Robotics (Italy)
Baxter International Acquires Baxa
Baxter Healthcare Acquires Prism Pharmaceuticals
Galenica Takes Over ViforUriachPharma
Fresenius Kabi Establishes Manufacturing Plant in Vietnam
Grifols to Set Up Form-Fill-Seal Production Lines for Parenteral Solutions
IVAL Pharma to Establish Pharmaceutical Plant in Uzbekistan
National Medical Solutions to Establish Medical Facility in Abu Dhabi
Baxter Healthcare Obtains USFDA Approval for AVIVA Intravenous Solutions (US)
FMC and ViforPharma Team Up to Form Vifor Fresenius
Marck Biosciences Acquire Injectible Facility of Ravish Infusion
Lijun Forms JV with TonghuaDongbao Pharmaceuticals
ADIH and Bram S. p. A. Ink Agreement for Wellpharma’s IV Production Facility
Hospira Signs Multi-product Agreements with MedAssets
Hospira Enters into Agreements with Novation
Mission Health System Commences Production of RIVA-produced IV Solution
Mission Health Systems Selects Automation Solution from IHS
Applied Research Associates Bags Contract for Packaged Intravenous Fluids
Hospira Announces Migration to Non-DEHP Based IV Administration Units

6. FOCUS ON SELECT GLOBAL PLAYERS

Actavis, Inc. (US)
B. Braun Melsungen AG (Germany)
Baxter International, Inc. (US)
Claris Lifesciences Ltd. (India)
Fresenius SE & Co. KGaA (Germany)
Fresenius KABI AG (Germany)
Sino-Swed Pharmaceutical Corp. Ltd. (China)
Hospira, Inc. (US)
Otsuka Pharmaceutical Factory, Inc.
Marck Biosciences Ltd. (India)
Sichuan Kelun Pharmaceutical Co., Ltd. (China)
Terumo Corporation (Japan)
The Galenica Group (Switzerland)
Vifor Pharma (Switzerland)

7. GLOBAL MARKET PERSPECTIVE

Table 25. World Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 26. World Historic Review for Intravenous Solutions (Parenteral Nutrition) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

Table 27. World 15-Year Perspective for Intravenous Solutions (Parenteral Nutrition) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for the Years 2004, 2013 and 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis

Table 28. The US Population by Age Group and Gender (2011) (includes corresponding Graph/Chart)

Impact of Patient Protection and Affordable Care Act (2010) on the IV Solutions Market
Increasing Usage of Intravenous Iron in the US
Cancer Trends in the US

Table 29. New Cancer Cases in the US by Gender and Affected Site: 2012

Table 30. New Cancer Cases in Males in US by Leading Site: 2012 (includes corresponding Graph/Chart)

Prevalence of Diabetes Mellitus in North America

Table 31. Prevalence of Diabetes Mellitus in North America: 2012 (includes corresponding Graph/Chart)

Table 32. North America Incidence of Type 1 Diabetes in Children: 2012 (includes corresponding Graph/Chart)

Strategic Corporate Developments
Focus on Select Major Players
B. Market Analytics

Table 33. The US Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 34. The US Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Cancer Statistics in Canada

Table 35. New Cancer Cases in Canada by Gender and Affected Site: 2012 (includes corresponding Graph/Chart)

Table 36. New Cancer Cases in Canada by Province: 2012 (includes corresponding Graph/Chart)

Table 37. New Cancer Cases in Canada by Age Group: 2012 (includes corresponding Graph/Chart)

Diabetes Statistics in Canada

Table 38. Prevalence of Diabetes Mellitus in Canada: 2012 (includes corresponding Graph/Chart)

Product Launches
B. Market Analytics

Table 39. Canadian Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 40. Canadian Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis

Table 41. Prevalence of Diabetes Mellitus in Japan: 2012 & 2030 (includes corresponding Graph/Chart)

Strategic Corporate Developments
Focus on Select Players
B. Market Analytics

Table 42. Japanese Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 43. Japanese Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Debt Crisis in Europe Affects Healthcare Industry
Healthcare System…. in State of Transition?
Age Statistics

Table 44. Europe Population Age Structure as a Percentage of Total Population for the Year 2011

Cancer Trends

Table 45. Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Prevalence of Diabetes Mellitus in Europe

Table 46. Prevalence of Diabetes Mellitus in Europe (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Strategic Corporate Initiatives
B. Market Analytics

Table 47. European Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) by Geographic Region   France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 48. European Historic Review for Intravenous Solutions (Parenteral Nutrition) by Geographic Region   France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

Table 49. European 15-Year Perspective for Intravenous Solutions (Parenteral Nutrition) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for the Years 2004, 2013 and 2018 (includes corresponding Graph/Chart)

4A. FRANCE

Market Analysis

Table 50. French Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 51. French Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Select Key Players
B. Market Analytics

Table 52. German Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 53. German Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4C. ITALY

Market Analysis

Table 54. Italian Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 55. Italian Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

Market Analysis

Table 56. The UK Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 57. The UK Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4E. SPAIN

A. Market Analysis
Grifols International S. A. – A Key Player
B. Market Analytics

Table 58. Spanish Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 59. Spanish Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4F. RUSSIA

Market Analysis

Table 60. Russian Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 61. Russian Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Focus on Select Key Players
B. Market Analytics

Table 62. Rest of European Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 63. Rest of European Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Cancer Trends in Asia-Pacific

Table 64. Cancer Incidence in Asia-Oceania by Site: 2011 (in Thousands) (includes corresponding Graph/Chart)

Diabetes Statistics

Table 65. Prevalence of Diabetes Mellitus in South East Asia (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %) (includes corresponding Graph/Chart)

Table 66. Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Table 67. Incidence of Type 1 Diabetes in Children by Select Countries in the Western Pacific: 2012 (includes corresponding Graph/Chart)

B. Market Analytics

Table 68. Asia-Pacific Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) by Geographic Region - China, Australia, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 69. Asia-Pacific Historic Review for Intravenous Solutions (Parenteral Nutrition) by Geographic Region - China, Australia, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

Table 70. Asia-Pacific 15-Year Perspective for Intravenous Solutions (Parenteral Nutrition) by Geographic Region - Percentage Breakdown of Value Sales for China, Australia, and Rest of Asia-Pacific Markets for the Years 2004, 2013 and 2018 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis

Table 71. Chinese Intravenous Solutions Products Packaging (2012): Percentage Share Breakdown of Volume Sales for Glass Bottles, and Plastic Bottles & Non-PVC Soft Bags (includes corresponding Graph/Chart)

Strategic Corporate Development
Focus on Select Key Players
B. Market Analytics

Table 72. Chinese Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 73. Chinese Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

5B. AUSTRALIA

Market Analysis

Table 74. Australian Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 75. Australian Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

5C. REST OF ASIA-PACIFIC

A. Market Analysis
An Overview of the IV Solutions Market in India
Strategic Corporate Developments
Focus on Select Key Players
B. Market Analytics

Table 76. Rest of Asia-Pacific Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 77. Rest of Asia-Pacific Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis

Table 78. Latin American Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 79. Latin American Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
The Middle East
Uganda
Prevalence Statistics of Diabetes Mellitus

Table 80. Prevalence of Diabetes Mellitus in Africa (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Table 81. Prevalence of Diabetes Mellitus in The Middle East & North Africa (2012 & 2030): Breakdown by Country and Age Group (In 000 People & %)

Product Launch
B. Market Analytics

Table 82. Rest of World Recent Past, Current and Future Analysis for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 83. Rest of World Historic Review for Intravenous Solutions (Parenteral Nutrition) Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 30 (including Divisions/Subsidiaries - 36)
The United States (10)
Japan (4)
Europe (11)
  France (1)
  Germany (3)
  The United Kingdom (1)
  Italy (1)
  Spain (1)
  Rest of Europe (4)
Asia-Pacific (Excluding Japan) (10)
Africa (1)